- Home
- GEVO vs ETON Comparison
GEVO vs ETON Comparison
Compare GEVO & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- ETON
- Stock Information
- Founded
- GEVO 2005
- ETON 2017
- Country
- GEVO United States
- ETON United States
- Employees
- GEVO N/A
- ETON N/A
- Industry
- GEVO Major Chemicals
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- ETON Health Care
- Exchange
- GEVO Nasdaq
- ETON Nasdaq
- Market Cap
- GEVO 285.1M
- ETON 428.5M
- IPO Year
- GEVO 2011
- ETON 2018
- Fundamental
- Price
- GEVO $1.14
- ETON $17.33
- Analyst Decision
- GEVO Buy
- ETON Strong Buy
- Analyst Count
- GEVO 2
- ETON 3
- Target Price
- GEVO $7.58
- ETON $27.67
- AVG Volume (30 Days)
- GEVO 2.4M
- ETON 221.4K
- Earning Date
- GEVO 05-13-2025
- ETON 05-13-2025
- Dividend Yield
- GEVO N/A
- ETON N/A
- EPS Growth
- GEVO N/A
- ETON N/A
- EPS
- GEVO N/A
- ETON N/A
- Revenue
- GEVO $16,915,000.00
- ETON $39,011,000.00
- Revenue This Year
- GEVO $617.82
- ETON $92.33
- Revenue Next Year
- GEVO $84.22
- ETON $52.62
- P/E Ratio
- GEVO N/A
- ETON N/A
- Revenue Growth
- GEVO N/A
- ETON 23.29
- 52 Week Low
- GEVO $0.48
- ETON $3.18
- 52 Week High
- GEVO $3.39
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- GEVO 49.70
- ETON 68.29
- Support Level
- GEVO $1.00
- ETON $16.43
- Resistance Level
- GEVO $1.14
- ETON $17.49
- Average True Range (ATR)
- GEVO 0.08
- ETON 0.88
- MACD
- GEVO 0.00
- ETON 0.19
- Stochastic Oscillator
- GEVO 60.87
- ETON 92.78
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.